FDA Human Medical Product User Fee Programs: In Brief
Description:
This report discusses FDA human medical product user fees for prescription drugs, medical devices, generic drugs, and biosimilars which are charged to companies producing the products and make up a large portion of the FDA's revenues. User fees are authorized in legislation on a five-year cycle, with authority for their actual collection and expenditure provided each year through the annual appropriations process. Appendix A outlines various features of the user fee programs.
Date:
November 21, 2017
Creator:
Dabrowska, Agata; Johnson, Judith A.; Sarata, Amanda K. & Thaul, Susan
Item Type:
Refine your search to only
Report
Partner:
UNT Libraries Government Documents Department